{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:16:31Z","timestamp":1782252991198,"version":"3.54.5"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Erythropoietic protoporphyria (EPP) is an autosomal recessive disorder of the heme biosynthesis pathway caused by pathogenic variants in <jats:italic>FECH<\/jats:italic> gene resulting in a decreased activity of ferrochelatase. Liver involvement is observed in 5%\u201320% of patients harbouring loss-of-function <jats:italic>FECH<\/jats:italic> variants and its manifestations are heterogeneous, ranging from mildly elevated liver transaminases, cholelithiasis to severe acute cholestatic hepatitis\/liver failure. This paper presents the case of a Polish infant with EPP associated with two novel missense <jats:italic>FECH<\/jats:italic> variants accompanied by other congenital anomalies, namely atrial septal defect and renal hypodysplasia. Progressive cholestatic liver disease (with subsequent congestive heart failure) was observed in the course of EPP. Erytropoietic protoporphyria should be considered in patients with hepatosplenomegaly and cholestasis accompanied by skin damage. The natural history of liver disease in the course of EPP could be determined by other factors, like the co-existence of congenital anomalies.<\/jats:p>","DOI":"10.3389\/fped.2025.1504181","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:50:16Z","timestamp":1739278216000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Cholestatic liver disease in the course of erythropoietic protoporphyria associated with renal hypodysplasia and atrial septal defect"],"prefix":"10.3389","volume":"13","author":[{"given":"Patryk","family":"Lipi\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Lipniacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Klaudel-Dreszler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Zi\u00f3\u0142kowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Kostrzewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Odnoczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"P\u0142oski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-4-19","article-title":"Erythropoietic protoporphyria","volume":"4","author":"Lecha","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jpeds.2018.06.001","article-title":"Diagnostic delay in erythropoietic protoporphyria","volume":"202","author":"Lala","year":"2018","journal-title":"J Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ymgme.2019.01.020","article-title":"Erythropoietic protoporphyria and X-linked protoporphyria: pathophysiology, genetics, clinical manifestations, and management","volume":"128","author":"Balwani","year":"2019","journal-title":"Mol Genet Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.17219\/acem\/58955","article-title":"Clinical, biochemical and molecular characteristics of the main types of Porphyria","volume":"25","author":"Szlendak","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1136\/gut.2006.097576","article-title":"Liver disease in erythropoietic protoporphyria: insights and implications for management","volume":"56","author":"Anstey","year":"2007","journal-title":"Gut"},{"key":"B6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3748\/wjg.v25.i7.880","article-title":"Diagnosis of erythropoietic protoporphyria with severe liver injury: a case report","volume":"25","author":"Liu","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.dld.2021.08.007","article-title":"Liver involvement in patients with erythropoietic protoporphyria","volume":"54","author":"Wensink","year":"2022","journal-title":"Dig Liver Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jaad.2022.08.036","article-title":"Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria","volume":"89","author":"Dickey","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/jimd.12545","article-title":"Development and validation of diagnostic algorithms for the laboratory diagnosis of porphyrias","volume":"45","author":"Lefever","year":"2022","journal-title":"J Inherit Metab Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1002\/ajmg.a.62455","article-title":"A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy","volume":"185","author":"Rydzanicz","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B11","first-page":"261","article-title":"Porphyrins","volume-title":"HPLC of Small Molecules: A Practical Approach","author":"Rossi","year":"1986"},{"key":"B12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng809","article-title":"The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH","volume":"30","author":"Gouya","year":"2006","journal-title":"Nat Genet"},{"key":"B13","first-page":"91","article-title":"A genotype-phenotype correlation between null allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria","volume":"48","author":"Minder","year":"2002","journal-title":"Cell Mol Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1001\/jamadermatol.2017.1557","article-title":"Clinical, biochemical, and genetic characterization of north American patients with erythropoietic protoporphyria and X-linked protoporphyria","volume":"153","author":"Balwani","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e14261","DOI":"10.1111\/petr.14261","article-title":"Reappraisal of liver transplantation for erythropoietic protoporphyria: a deadly combination of disease recurrence and biliary complication","volume":"26","author":"Endo","year":"2022","journal-title":"Pediatr Transplant"},{"key":"B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/bmt.2009.132","article-title":"The role for BMT in erythropoietic protoporphyria","volume":"45","author":"Wahlin","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1896","DOI":"10.1542\/peds.2006-0833","article-title":"Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria","volume":"118","author":"Rand","year":"2006","journal-title":"Pediatrics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"151859","DOI":"10.1016\/j.anndiagpath.2021.151859","article-title":"Liver involvement in patients with erythropoietic protoporphyria: retrospective analysis of clinicopathological features of 5 cases","volume":"56","author":"Zhao","year":"2022","journal-title":"Ann Diagn Pathol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2020.08.004","article-title":"Kidney transplantation improves the clinical outcomes of acute intermittent Porphyria","volume":"131","author":"Lazareth","year":"2020","journal-title":"Mol Genet Metab"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1504181\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:50:19Z","timestamp":1739278219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1504181\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":20,"alternative-id":["10.3389\/fped.2025.1504181"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1504181","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"article-number":"1504181"}}